Carlyle, Brighton Park to invest $200 mn in Bengaluru firm, Indegene
Updated:
Updated:
February 03, 2021 01:33 IST
Indegene had made significant organic and inorganic investments in building a technology portfolio that caters exclusively to healthcare.
Share Article
AAA
Indegene had made significant organic and inorganic investments in building a technology portfolio that caters exclusively to healthcare.
The Carlyle Group and Brighton Park Capital, an investor-centric investment firm, will acquire a minority stake in Bengaluru-based Indegene Lifesystems, an enterprise healthtech solutions provider, for $200 million (around Rs 1,500 crore).
The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment into the company, said Carlyle Group and Brighton Park Capital in a joint statement on Wednesday.

Related Keywords

China , Japan , United States , India , America , Manish Gupta , Neeraj Bharadwaj , Indegene Lifesystems , Carlyle Asia , Infosys , Carlyle Group , Brighton Park Capital , Bengaluru Based Indegene Lifesystems , Managing Director , North America , Brighton Park , சீனா , ஜப்பான் , ஒன்றுபட்டது மாநிலங்களில் , இந்தியா , அமெரிக்கா , மனிஷ் குப்தா , நீரஜ் பரத்வாஜ் , கார்லைல் ஆசியா , இண்பொசயிச் , கார்லைல் குழு , பிரகாசமான பூங்கா மூலதனம் , நிர்வகித்தல் இயக்குனர் , வடக்கு அமெரிக்கா , பிரகாசமான பூங்கா ,